« Return to News | Study Conduct

DaVita Clinical Research expands near Denver

Monday, February 13, 2012 03:00 PM

DaVita Clinical Research (DCR), a provider of clinical research services focused on kidney research, will enter the St Anthony Hospital campus in Lakewood, Colo.

The 35,000-square-foot unit will be physically connected to St. Anthony Hospital in Medical Plaza One and will be operational in mid-2012. The facility will hold 80 beds, which increases DCR’s physical capacity from 42 to 122 beds in North America, and is expected to create more than 50 specialized jobs.

“We are excited about our partnership with a hospital that has such a strong reputation with health care professionals and patients throughout Colorado,” said Kent Thiry, DaVita chairman and CEO.

The facility will support high-risk studies and an expanded ability to support normal, healthy volunteer phase I clinical studies. The custom-designed facility will provide DCR with the capacity needed to grow its clinical research business in existing specialty populations, including renal patients.

“Our partnership with DCR adds value to the community and Centura hospitals by providing new opportunities for local patients and collaborative relationships in the medical teams that can ultimately improve the quality of care,” stated Jeff Brickman, CEO of St. Anthony Hospital and president of Centura Health’s Mountains North Denver Operating Group, which includes St. Anthony Hospital.

“This opportunity expands our leadership role in renal-related research and further diversifies our research capabilities,” said DCR president Chris Rucker.

Share:          
CWWeekly

May 21

Parexel consultant testifies on FDA biosimilars guidance

Global Telecom Testing checks ex-U.S. toll-free phone lines for multinational clinical trials

To read the full articles for this issue of CWWeekly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

CWWeekly

May

Newer sites most optimistic about the future
Investigative sites of all sizes, from part-time physician-run sites to large dedicated research centers, report a rebound in operating conditions, according to a new CenterWatch analysis, yet sites from each subgroup indicate they have concerns…

Risk-based monitoring slow to catch on with industry
It's estimated that the cost of physically sending monitors to all investigative sites at regular intervals, a model the industry itself developed and has adhered to for about a decade, eats up one-third to one-half of…

Eye On Millennium
Millennium, The Takeda Oncology Company, discovers and develops novel treatments applying world-class recombinant technology to a wide variety of oncology disease targets…

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2012 CenterWatch.